Swiss pharmaceutical giant Roche said Monday it is accelerating the timeline for its Wegovy rival weight loss drugs following promising early stage trial data.
Related Posts
Honda shares fall 2% after media reports on potential merger with Nissan
Post Content
At least 15 still alive under Bangkok skyscraper rubble, rescuers say
Rescuers are working to pull people from the remains of the tower, which dramatically collapsed on Friday.
SoftBank shares slide over 8% amid renewed pressure on AI-linked stocks
Shares of Japan’s SoftBank Group plunged, following a broader slump in AI-related stocks as investors once again grew wary of…